Zipcode Bio is a biotechnology company specializing in the development of next-generation nucleic acid applications that are accessible, widely distributable, and superior in efficacy and safety. It is co-Founded by Dr. Drew Weissman, Dr. Virgil Percec and Dr. Jason Zhang in Nov. 2023. The scientific strength is based on the co-founders’ deep knowledge in RNA medicine, breakthrough DNP technology, and focus on unmet medical needs. Zipcode Bio stands at the forefront of developing revolutionary solutions with the potential to transform patient care. Zipcode Bio has assembled a dynamic team committed to pushing scientific boundaries and developing novel therapeutics to address unmet healthcare needs. The company’s dedication to innovation, precision, and accessibility underscores its mission to improve therapeutic outcomes and contribute to the evolution of global healthcare.
For more information, please contact jason.zhang@zipcodebio.com